Literature DB >> 33528690

Major histocompatibility complex (MHC) associations with diseases in ethnic groups of the Arabian Peninsula.

Halima Al Naqbi1,2, Aurélie Mawart1, Jawaher Alshamsi3, Habiba Al Safar1,2,3, Guan K Tay4,5,6,7,8.   

Abstract

Since the discovery of human leukocyte antigens (HLAs), the function of major histocompatibility complex (MHC) gene families in a wide range of diseases have been the subject of research for decades. In particular, the associations of autoimmune disorders to allelic variants and candidate genes encoding the MHC are well documented. However, despite decades of research, the knowledge of MHC associations with human disease susceptibility have been predominantly studied in European origin, with limited understanding in different populations and ethnic groups. This is particularly evident in countries and ethnic populations of the Arabian Peninsula. Human MHC haplotypes, and its association with diseases, of the variable ethnic groups of this region are poorly studied. This review compiled published manuscripts that have reported a list of autoimmune diseases (insulin-dependent diabetes mellitus, systemic lupus erythematosus, myasthenia gravis, rheumatoid arthritis, psoriasis vulgaris, and multiple sclerosis) associated with MHC class I and class II in the populations of the Arabian Peninsula, specifically Bahrain, Kuwait, Oman, Qatar, Saudi Arabia, the United Arab Emirates, and Yemen. Data available was compared with other three ethnic groups, namely Caucasians, Asians, and Africans. The limited data available in the public domain on the association between MHC gene and autoimmune diseases highlight the challenges in the Middle Eastern region.

Entities:  

Keywords:  Arab; Disease association; HLA; MHC

Year:  2021        PMID: 33528690      PMCID: PMC7946680          DOI: 10.1007/s00251-021-01204-x

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  102 in total

1.  Polymorphic markers in MHC class II/III region: a study on Italian patients with myasthenia gravis.

Authors:  D Franciotta; M Cuccia; E Dondi; G Piccolo; V Cosi
Journal:  J Neurol Sci       Date:  2001-09-15       Impact factor: 3.181

Review 2.  Multiple sclerosis, vitamin D, and HLA-DRB1*15.

Authors:  Lahiru Handunnetthi; Sreeram V Ramagopalan; George C Ebers
Journal:  Neurology       Date:  2010-06-08       Impact factor: 9.910

Review 3.  Nomenclature for factors of the HLA system, 2010.

Authors:  S G E Marsh; E D Albert; W F Bodmer; R E Bontrop; B Dupont; H A Erlich; M Fernández-Viña; D E Geraghty; R Holdsworth; C K Hurley; M Lau; K W Lee; B Mach; M Maiers; W R Mayr; C R Müller; P Parham; E W Petersdorf; T Sasazuki; J L Strominger; A Svejgaard; P I Terasaki; J M Tiercy; J Trowsdale
Journal:  Tissue Antigens       Date:  2010-04

4.  Assessment of complement C4 gene copy number using the paralog ratio test.

Authors:  Michelle M A Fernando; Lora Boteva; David L Morris; Bi Zhou; Yee Ling Wu; Marja-Liisa Lokki; Chack Yung Yu; John D Rioux; Edward J Hollox; Timothy J Vyse
Journal:  Hum Mutat       Date:  2010-07       Impact factor: 4.878

Review 5.  Genetics of type 1 diabetes.

Authors:  Andrea K Steck; Marian J Rewers
Journal:  Clin Chem       Date:  2011-01-04       Impact factor: 8.327

Review 6.  Genetic Epidemiology of Type 1 Diabetes in the 22 Arab Countries.

Authors:  Hatem Zayed
Journal:  Curr Diab Rep       Date:  2016-05       Impact factor: 4.810

7.  HLA-DR allele polymorphism and multiple sclerosis in Chinese populations: a meta-analysis.

Authors:  Wei Qiu; Ian James; William M Carroll; Frank L Mastaglia; Allan G Kermode
Journal:  Mult Scler       Date:  2010-12-21       Impact factor: 6.312

8.  Contribution of selective HLA-DRB1/DQB1 alleles and haplotypes to the genetic susceptibility of type 1 diabetes among Lebanese and Bahraini Arabs.

Authors:  Fayza A Al-Jenaidi; Saria F Wakim-Ghorayeb; Abduljabbar Al-Abbasi; Mona R Arekat; Noha Irani-Hakime; Pierre Najm; Khadija Al-Ola; Ayesha A Motala; Wassim Y Almawi
Journal:  J Clin Endocrinol Metab       Date:  2005-06-28       Impact factor: 5.958

9.  HLA typing using next-generation sequencing for Chinese juvenile- and adult-onset myasthenia gravis patients.

Authors:  Xuelin Feng; Wenhui Li; Jie Song; Xiaoni Liu; Yuehua Gu; Chong Yan; Hui Wu; Jianying Xi; Shuizhen Zhou; Chongbo Zhao
Journal:  J Clin Neurosci       Date:  2018-10-24       Impact factor: 1.961

10.  Structural basis of the polymorphism of human complement components C4A and C4B: gene size, reactivity and antigenicity.

Authors:  C Y Yu; K T Belt; C M Giles; R D Campbell; R R Porter
Journal:  EMBO J       Date:  1986-11       Impact factor: 11.598

View more
  5 in total

1.  HLA repertoire of 115 UAE nationals infected with SARS-CoV-2.

Authors:  Halima Alnaqbi; Guan K Tay; Herbert F Jelinek; Amirtharaj Francis; Eman Alefishat; Sarah El Haj Chehadeh; Amna Tahir Saeed; Mawada Hussein; Bassam H Mahboub; Maimunah Uddin; Nawal Alkaabi; Habiba S Alsafar
Journal:  Hum Immunol       Date:  2021-08-21       Impact factor: 2.850

Review 2.  Human Leukocyte Antigen (HLA) System: Genetics and Association with Bacterial and Viral Infections.

Authors:  Sadeep Medhasi; Narisara Chantratita
Journal:  J Immunol Res       Date:  2022-05-26       Impact factor: 4.493

3.  Characterizing the diversity of MHC conserved extended haplotypes using families from the United Arab Emirates.

Authors:  Halima Alnaqbi; Guan K Tay; Sarah El Hajj Chehadeh; Habiba Alsafar
Journal:  Sci Rep       Date:  2022-05-03       Impact factor: 4.996

Review 4.  Emerging Roles of MHC Class I Region-Encoded E3 Ubiquitin Ligases in Innate Immunity.

Authors:  Xiuzhi Jia; Chunyuan Zhao; Wei Zhao
Journal:  Front Immunol       Date:  2021-06-10       Impact factor: 7.561

5.  Segregation Analysis of Genotyped and Family-Phased, Long Range MHC Classical Class I and Class II Haplotypes in 5 Families With Type 1 Diabetes Proband in the United Arab Emirates.

Authors:  Guan K Tay; Halima Al Naqbi; Aurélie Mawart; Zahrah Baalfaqih; Anoud Almaazmi; Asma Deeb; Habiba Alsafar
Journal:  Front Genet       Date:  2021-06-30       Impact factor: 4.599

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.